Prana Therapies
Encinitas, US · Founded 2024 · Delaware corporation
Biotech
Founders & leadership
MS
Miguel SanjuanExecutive Officer, Director
SG
Sheila GujrathiExecutive Officer, Director
BA
Ben AuspitzDirector
AB
Alexis BorisyDirector
SG
Sheila Gujrathi, M.D.Executive Officer, Director
HO
Hector OrtegaExecutive Officer
RS
Ryan SullivanExecutive Officer
Reported raises · per SEC filings
Form D private placements▶$40.2MraisedAug 2026 · 9 investors · BiotechnologyRule 506(b)
▶$40.2MraisedAug 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ben AuspitzDirector
- Alexis BorisyDirector
- Sheila Gujrathi, M.D.Executive Officer, Director
- Hector OrtegaExecutive Officer
- Ryan SullivanExecutive Officer
- Offering amount
- $40.2M
- Amount sold
- $40.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$5MraisedJul 2024 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedJul 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel SanjuanExecutive Officer, Director
- Sheila GujrathiExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $5M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.